RxDoctor Payments Data

Komal Desai, MD

Ophthalmology · Kansas City, MONPI 1841298916

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 78 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Alcon accounts for 72.0% of it on its own, with 12 other manufacturers making up the rest.

$4,503in general payments, 2019–2025

Across 78 payments — averaging $57.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alcon$3K
  • Bausch & Lomb Americas Inc.$423
  • Sun Pharmaceutical Industries Inc.$299
  • Sight Sciences, Inc.$220
  • Mallinckrodt Enterprises LLC$114
  • Carl Zeiss Meditec USA, Inc.$40
  • plus $163 from 7 others
$172,382in research payments, 2019–2025

Across 15 payments — averaging $11,492 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AbbVie$172K

What the payments were for

  • Food & beverage$4,503100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,503 in reported general payments places this provider in the 75th percentile of 286 ophthalmology providers in Missouri.

See all ophthalmology providers in Missouri

Medicare billing

Part B allowed, 2024
$203,094
Medicare patients
770
Services billed
1,664

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Prednisolone Acetate296$8,372
CombiganBrimonidine Tartrate/Timolol11$4,112
Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol12$2,941
Ofloxacin204$2,078
Timolol Maleate13$1,389
Latanoprost94$1,306
Ketorolac Tromethamine49$900
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha58$750
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat26$333
Brimonidine Tartrate12$272
ErythromycinErythromycin Base13$146

Paid to pharmacies, not to this prescriber.

Other ophthalmology in Kansas City

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →